SEARCH HEALTH CONDITIONS BY ALPHABETS
Meningeal Leukemia
Medications for Meningeal Leukemia
Other names: Cancer, Meningeal Leukemia; Leukemia, Meningeal
Around Meningeal Leukemia: Meningeal Leukemia is infiltration of the meninges by leukemic cells, a frequent occurrence in relapse after systemic administration of chemotherapeutic agents into leukemia patients.
Drugs Used to Treat Meningeal Leukemia
This list of medications are used at the treatment of this condition, or somehow associated with.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| methotrexate | Rx | X | N | X | Insert inspection | 0.0 | |
Generic name: methotrexate systemic Brand name: Trexall Medication class: antimetabolites, Anti-rheumatics, antipsoriatics, other immunosuppressants For users: dosage, interactions, For professionals: a Z Medication Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Trexall | Rx | X | N | X | Insert inspection | 0.0 | |
Generic name: methotrexate systemic Medication class: antimetabolites, Anti-rheumatics, antipsoriatics, other immunosuppressants For users: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| cytarabine | Rx | D | N | Insert inspection | 0.0 | ||
Generic name: cytarabine systemic Medication class: antimetabolites For users: dosage, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | Prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Off Label | This drug Might Not Be approved by the FDA for treating this illness. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the embryo in the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in elderly women clearly outweigh potential rewards. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | includes a high potential for misuse. Has no accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| Two | includes a high potential for misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause severe emotional or physical dependence. |
| 3 | features a possibility for abuse less than those in programs 1 and 2 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse relative to those in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | includes a very low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your healthcare provider to be sure the information displayed on these pages pertains to a circumstances.
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Top USA Pharma Companies
Popular Categories
Health Condition
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Easily find an affordable health insurance plan
